High-resolution respirometry in human endomyocardial biopsies shows reduced ventricular oxidative capacity related to heart failure.
Daniel ScheiberTomas JelenikElric ZweckPatrick HornHeinz-Peter SchultheissDirk LassnerUdo BoekenDiyar SaeedMalte KelmMichael RodenRalf WestenfeldJulia SzendroediPublished in: Experimental & molecular medicine (2019)
The lifetime risk of developing heart failure is approximately 20%, and survival rates remain poor. Myocardial mitochondrial function has been suggested to play a pivotal role in heart failure pathophysiology. Human studies on ex vivo mitochondrial function have mostly been limited to atrial tissue obtained during open heart surgery and have provided contradictory results. This study aimed at measuring myocardial mitochondrial function in transcatheter ventricular endomyocardial biopsies and assessing the relationship between oxidative capacity and heart function. We enrolled 40 heart failure patients undergoing ventricular assist device surgery or heart transplantation (34 males, age 57 ± 11 years, body mass index 26.6 ± 4.8 kg/m2) and 29 heart transplant recipients of comparable age and body mass index with normal left ventricular function undergoing surveillance biopsies (23 males, 57 ± 12 years, body mass index 26.2 ± 4.1 kg/m2). High-resolution respirometry was established in the myocardium to measure oxidative capacity ex vivo. The mitochondrial oxidative capacity was 90% higher in ventricular compared to atrial tissues (n = 11, p < 0.01) of explanted hearts. Respiration rates were comparable in ventricular samples of heart failure patients obtained during open heart surgery by standard tissue preparation or ex vivo endomyocardial biopsy (r = 0.9988, p < 0.0001, n = 8), and the mitochondrial oxidative capacity in samples from these patients remained stable for 8 h when stored in either of two common preservation buffers. The oxidative capacity was 44% lower in heart failure than in transplant recipients (67 ± 3 vs. 97 ± 5 pmol/[s mg], p < 0.0001) and correlated positively with heart function (r = 0.49, p < 0.01). High-resolution respirometry of ventricular tissue is feasible in transcatheter biopsies, facilitating clinical studies on myocardial mitochondrial function in patients not undergoing heart surgery.
Keyphrases
- heart failure
- left ventricular
- minimally invasive
- body mass index
- high resolution
- atrial fibrillation
- cardiac resynchronization therapy
- coronary artery bypass
- left atrial
- hypertrophic cardiomyopathy
- acute myocardial infarction
- endothelial cells
- acute heart failure
- catheter ablation
- oxidative stress
- patients undergoing
- aortic stenosis
- ejection fraction
- mitral valve
- weight gain
- surgical site infection
- newly diagnosed
- end stage renal disease
- physical activity
- mass spectrometry
- ultrasound guided
- prognostic factors
- transcatheter aortic valve replacement
- acute coronary syndrome
- fine needle aspiration
- high speed